|
1
|
Pereira D, Ramos E and Branco J:
Osteoarthritis. Acta Med Port. 28:99–106. 2015. View Article : Google Scholar
|
|
2
|
Nelson AE: Osteoarthritis year in review
2017: Clinical. Osteoarthritis Cartilage. 26:319–325. 2018.
View Article : Google Scholar
|
|
3
|
Saccomano SJ: Osteoarthritis treatment:
Decreasing pain, improving mobility. Nurse Pract. 43:49–55. 2018.
View Article : Google Scholar
|
|
4
|
Palazzo C, Nguyen C, Lefevre-Colau MM,
Rannou F and Poiraudeau S: Risk factors and burden of
osteoarthritis. Ann Phys Rehabil Med. 59:134–138. 2016. View Article : Google Scholar
|
|
5
|
Vina ER and Kwoh CK: Epidemiology of
osteoarthritis: Literature update. Curr Opin Rheumatol. 30:160–167.
2018. View Article : Google Scholar
|
|
6
|
Berenbaum F: Osteoarthritis as an
inflammatory disease (osteoarthritis is not osteoarthrosis!).
Osteoarthritis Cartilage. 21:16–21. 2013. View Article : Google Scholar
|
|
7
|
Farnaghi S, Crawford R, Xiao Y and
Prasadam I: Cholesterol metabolism in pathogenesis of
osteoarthritis disease. Int J Rheum Dis. 20:131–140. 2017.
View Article : Google Scholar
|
|
8
|
Xue JF, Shi ZM, Zou J and Li XL:
Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of
articular chondrocytes and attenuates inflammatory response in rats
with osteoarthritis. Biomed Pharmacother. 89:1252–1261. 2017.
View Article : Google Scholar
|
|
9
|
Lin C, Shao Y, Zeng C, Zhao C, Fang H,
Wang L, Pan J, Liu L, Qi W, Feng X, et al: Blocking PI3K/AKT
signaling inhibits bone sclerosis in subchondral bone and
attenuates post-traumatic osteoarthritis. J Cell Physiol.
233:6135–6147. 2018. View Article : Google Scholar
|
|
10
|
Chen J, Crawford R and Xiao Y: Vertical
inhibition of the PI3K/Akt/mTOR pathway for the treatment of
osteoarthritis. J Cell Biochem. 114:245–249. 2013. View Article : Google Scholar
|
|
11
|
Farnaghi S, Crawford R, Xiao Y and
Prasadam I: Cholesterol metabolism in pathogenesis of
osteoarthritis disease. Int J Rheum. 20:131–140. 2017. View Article : Google Scholar
|
|
12
|
de Munter W, van der Kraan PM, van den
Berg WB and van Lent PL: High systemic levels of low-density
lipoprotein cholesterol: Fuel to the flames in inflammatory
osteoarthritis? Rheumatology. 55:16–24. 2016. View Article : Google Scholar
|
|
13
|
Beier F: Cholesterol and cartilage do not
mix well. Nat Rev Rheumatol. 15:253–254. 2019. View Article : Google Scholar
|
|
14
|
Varshney P and Saini N: PI3K/AKT/mTOR
activation and autophagy inhibition plays a key role in increased
cholesterol during IL-17A mediated inflammatory response in
psoriasis. Biochim Biophys Acta Mol Basis Dis. 1864((5 Pt A)):
1795–1803. 2018. View Article : Google Scholar
|
|
15
|
Fuentes M, Santander N and Cortés V:
Insulin increases cholesterol uptake, lipid droplet content, and
apolipoprotein B secretion in CaCo-2 cells by upregulating SR-BI
via a PI3K, AKT, and mTOR-dependent pathway. J Cell Biochem.
October 2–2018.(Online ahead of print). doi: 10.1002/jcb.27410.
|
|
16
|
Yang Y, Gu Y, Zhao H and Zhang S: Loganin
attenuates osteoarthritis in rats by inhibiting IL-1β-induced
catabolism and apoptosis in chondrocytes via regulation of
phosphatidylinositol 3-lkinases (PI3K)/Akt. Med Sci Monit.
25:4159–4168. 2019. View Article : Google Scholar
|
|
17
|
Li X, Wu D, Hu Z, Xuan J, Ding X, Zheng G,
Feng Z, Ni W and Wu A: The protective effect of ligustilide in
osteoarthritis: An in vitro and in vivo study. Cell Physiol
Biochem. 48:2583–2595. 2018. View Article : Google Scholar
|
|
18
|
Pan T, Cheng TF, Jia YR, Li P and Li F:
Anti-rheumatoid arthritis effects of traditional Chinese herb
couple in adjuvant-induced arthritis in rats. J Ethnopharmacol.
205:1–7. 2017. View Article : Google Scholar
|
|
19
|
Salimzadeh A, Ghourchian A, Choopani R,
Hajimehdipoor H, Kamalinejad M and Abolhasani M: Effect of an
orally formulated processed black cumin, from Iranian traditional
medicine pharmacopoeia, in relieving symptoms of knee
osteoarthritis: A prospective, randomized, double-blind and
placebo-controlled clinical trial. Int J Rheum Dis. 20:691–701.
2017. View Article : Google Scholar
|
|
20
|
Xu X, Lv H, Li X, Su H, Zhang X and Yang
J: Danshen attenuates osteoarthritis-related cartilage degeneration
through inhibition of NF-kappaB signaling pathway in vivo and in
vitro. Bio Cell Biol. 95:644–651. 2017. View Article : Google Scholar
|
|
21
|
Wang L and Ma Q: Clinical benefits and
pharmacology of scutellarin: A comprehensive review. Pharmacol
Ther. 190:105–127. 2018. View Article : Google Scholar
|
|
22
|
Li CY, Wang Q, Wang X, Li G, Shen S and
Wei X: Scutellarin inhibits the invasive potential of malignant
melanoma cells through the suppression epithelial-mesenchymal
transition and angiogenesis via the PI3K/Akt/mTOR signaling
pathway. Eur J Pharmacol. 858:1724632019. View Article : Google Scholar
|
|
23
|
Lv WL, Liu Q, An JH and Song XY:
Scutellarin inhibits hypoxia-induced epithelial-mesenchymal
transition in bladder cancer cells. J Cell Physiol.
234:23169–23175. 2019. View Article : Google Scholar
|
|
24
|
Liu F, Li L, Lu W, Ding Z, Huang W, Li YT,
Cheng C, Shan WS, Xu J, He W, et al: Scutellarin ameliorates
cartilage degeneration in osteoarthritis by inhibiting the
Wnt/β-catenin and MAPK signaling pathways. Int Immunopharmacol.
78:1059542020. View Article : Google Scholar
|
|
25
|
Lane NE, Shidara K and Wise BL:
Osteoarthritis year in review 2016: Clinical. Osteoarthritis
Cartilage. 25:209–215. 2017. View Article : Google Scholar
|
|
26
|
Zhang W, Ouyang H, Dass CR and Xu J:
Current research on pharmacologic and regenerative therapies for
osteoarthritis. Bone Res. 4:150402016. View Article : Google Scholar
|
|
27
|
Luo P, Zhang Z, Yi T, Zhang H, Liu X and
Mo Z: Anti-inflammatory activity of the extracts and fractions from
Erigeron multiradiatus through bioassay-guided procedures. J
Ethnopharmacol. 119:232–237. 2008. View Article : Google Scholar
|
|
28
|
Watt FE: Osteoarthritis biomarkers: Year
in review. Osteoarthritis Cartilage. 26:312–318. 2018. View Article : Google Scholar
|
|
29
|
Zhang L, Sun S, Li W, Zhang W, Wang X and
Yang SY: Effect of Scutellarin inhibits collagen-induced arthritis
through TLR4/NF-κB-mediated inflammation. Mol Med Rep.
16:5555–5560. 2017. View Article : Google Scholar
|
|
30
|
Wang W, Li J, Li F, Peng J, Xu M,
Shangguan Y, Li Y, Zhao Y, Qiu C, Qu R, et al: Scutellarin
suppresses cartilage destruction in osteoarthritis mouse model by
inhibiting the NF-κB and PI3K/AKT signaling pathways. Int
Immunopharmacol. 77:1059282019. View Article : Google Scholar
|
|
31
|
Naderi Z, Mozaffari-Khosravi H, Dehghan A,
Nadjarzadeh A and Huseini HF: Effect of ginger powder
supplementation on nitric oxide and C-reactive protein in elderly
knee osteoarthritis patients: A 12-week double-blind randomized
placebo-controlled clinical trial. J Tradit Complement Med.
6:199–203. 2015. View Article : Google Scholar
|
|
32
|
Kerkhof HJ, Bierma-Zeinstra SM,
Castano-Betancourt MC, de Maat MP, Hofman A, Pols HA, Rivadeneira
F, Witteman JC, Uitterlinden AG and van Meurs JB: Serum C reactive
protein levels and genetic variation in the CRP gene are not
associated with the prevalence, incidence or progression of
osteoarthritis independent of body mass index. Ann Rheum Dis.
69:1976–1982. 2010. View Article : Google Scholar
|
|
33
|
Xu X, Liu X, Yang Y, He J, Gu H, Jiang M,
Huang Y, Liu X and Liu L: Resveratrol inhibits the development of
obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling
pathways. Connect Tissue Res. 60:571–582. 2019. View Article : Google Scholar
|
|
34
|
Gao F and Zhang S: Salicin inhibits
AGE-induced degradation of type II collagen and aggrecan in human
SW1353 chondrocytes: Therapeutic potential in osteoarthritis. Artif
Cells Nanomed Biotechnol. 47:1043–1049. 2019. View Article : Google Scholar
|
|
35
|
Hong GU, Lee JY, Kang H, Kim TY, Park JY,
Hong EY, Shin YH, Jung SH, Chang HB, Kim YH, et al: Inhibition of
osteoarthritis-eelated molecules by isomucronulatol
7-O-β-d-glucoside and Ecliptasaponin A in IL-1β-stimulated
chondrosarcoma cell model. Molecules. 23:28072018.doi:
10.3390/molecules23112807. View Article : Google Scholar
|
|
36
|
Otero M, Peng H, Hachem KE, Culley KL,
Wondimu EB, Quinn J, Asahara H, Tsuchimochi K, Hashimoto K and
Goldring MB: ELF3 modulates type II collagen gene (COL2A1)
transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven
histone acetyltransferase activity. Connect Tissue Res. 58:15–26.
2017. View Article : Google Scholar
|
|
37
|
Ouyang Y, Wang W, Tu B, Zhu Y, Fan C and
Li Y: Overexpression of SOX9 alleviates the progression of human
osteoarthritis in vitro and in vivo. Drug Des Devel Ther.
13:2833–2842. 2019. View Article : Google Scholar
|
|
38
|
Zheng W, Feng Z, You S, Zhang H, Tao Z,
Wang Q, Chen H and Wu Y: Fisetin inhibits IL-1β-induced
inflammatory response in human osteoarthritis chondrocytes through
activating SIRT1 and attenuates the progression of osteoarthritis
in mice. Int Immunopharmacol. 45:135–147. 2017. View Article : Google Scholar
|
|
39
|
Mobasheri A, Rayman MP, Gualillo O, Sellam
J, van der Kraan P and Fearon U: The role of metabolism in the
pathogenesis of osteoarthritis. Nat Rev Rheumatol. 13:302–311.
2017. View Article : Google Scholar
|
|
40
|
de Munter W, van den Bosch MH, Slöetjes
AW, Croce KJ, Vogl T, Roth J, Koenders MI, van de Loo FA, van den
Berg WB, van der Kraan PM, et al: High LDL levels lead to increased
synovial inflammation and accelerated ectopic bone formation during
experimental osteoarthritis. Osteoarthritis Cartilage. 24:844–855.
2016. View Article : Google Scholar
|
|
41
|
Tsezou A, Iliopoulos D, Malizos KN and
Simopoulou T: Impaired expression of genes regulating cholesterol
efflux in human osteoarthritic chondrocytes. J Orthop Res.
28:1033–1039. 2010. View Article : Google Scholar
|
|
42
|
Choi WS, Lee G, Song WH, Koh JT, Yang J,
Kwak JS, Kim HE, Kim SK, Son YO, Nam H, et al: The
CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates
osteoarthritis. Nature. 566:254–258. 2019. View Article : Google Scholar
|
|
43
|
Li Q, Wu JH, Guo DJ, Cheng HL, Chen SL and
Chan SW: Suppression of diet-induced hypercholesterolemia by
scutellarin in rats. Planta Med. 75:1203–1208. 2009. View Article : Google Scholar
|
|
44
|
Fan H, Ma X, Lin P, Kang Q, Zhao Z, Wang
L, Sun D, Cheng J and Li Y: Scutellarin prevents nonalcoholic fatty
liver disease (NAFLD) and hyperlipidemia via PI3K/AKT-dependent
activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in
rats. Med Sci Monit. 23:5599–5612. 2017. View Article : Google Scholar
|
|
45
|
Tang SL, Gao YL and Hu WZ: Scutellarin
inhibits the metastasis and cisplatin resistance in glioma cells.
OncoTargets Ther. 12:587–598. 2019. View Article : Google Scholar
|
